Obesity is the disease of our modern affluent societies. More than one billion people suffer from it globally, which is double the amount of 1990. According to predictions, by the year 2035 they could be two billion. In the USA, 32% of the male adult population and 37% of the female adult population is obese. The Danish pharmaceutical company Novo Nordisk has recently launched Ozempic, a miracle drug for the obese that has taken the American market by storm (and not only). However, despite the facade of optimism, there are thousands of sides to consider when it come to issues such as prevention and accessibility to these new cures.